Smallcap Bear 3X Direxion (TZA) 16.65 $TZA Watch for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Smallcap Bear 3X Direxion (TZA) 16.65 $TZA

Watch for Direxion Daily Small Cap Bear 3X Shares to Potentially Pullback After Gaining 4.60% Yesterday
Comtex SmarTrend(R) - Mon Apr 07, 4:14PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $16.40 to a high of $17.33. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high of $16.48 on volume of 33.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Daily Small Cap Bear 3x Shares (TZA)
Trading Central - Mon Apr 07, 10:33AM CDT
From a technical view, the ETF is trading above a key support level set at $14.30. Regarding technical indicators, the daily RSI is above its neutrality area. On a relative basis against the S&P500, the Direxion Daily Small Cap Bear 3x Shares is...

Look for Shares of Direxion Daily Small Cap Bear 3X Shares to Potentially Rebound after Yesterday's 3.72% Sell Off
Comtex SmarTrend(R) - Tue Apr 01, 5:33PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.94 to a high of $15.51. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $15.49 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of Direxion Daily Small Cap Bear 3X Shares After 3.72% Loss
Comtex SmarTrend(R) - Tue Apr 01, 5:33PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.94 to a high of $15.51. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $15.49 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Direxion Daily Small Cap Bear 3X Shares Has Returned 13.9% Since SmarTrend Recommendation (TZA)
Comtex SmarTrend(R) - Tue Apr 01, 9:27AM CDT
SmarTrend identified a Downtrend for Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) on February 12th, 2014 at $17.85. In approximately 2 months, Direxion Daily Small Cap Bear 3X Shares has returned 13.93% as of today's recent price of $15.36.

Direxion Daily Small Cap Bear 3X Shares Set to Possibly Pullback After Yesterday's Rally of 3.35%
Comtex SmarTrend(R) - Mon Mar 24, 4:13PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.71 to a high of $15.85. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $15.13 on volume of 22.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 3.35% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Mar 24, 4:11PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.71 to a high of $15.85. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $15.13 on volume of 22.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for Direxion Daily Small Cap Bear 3X Shares to Potentially Rebound After Falling 1.43% Yesterday
Comtex SmarTrend(R) - Mon Mar 17, 4:02PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.80 to a high of $15.27. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $14.87 on volume of 16.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.43%, Direxion Daily Small Cap Bear 3X Shares Offers Investors Better Value
Comtex SmarTrend(R) - Mon Mar 17, 4:02PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.80 to a high of $15.27. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $14.87 on volume of 16.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Direxion Daily Small Cap Bear 3X Shares Down 12.6% Since SmarTrend Downtrend Call (TZA)
Comtex SmarTrend(R) - Thu Mar 13, 5:27PM CDT
SmarTrend identified a Downtrend for Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) on February 12th, 2014 at $17.85. In approximately 4 weeks, Direxion Daily Small Cap Bear 3X Shares has returned 12.58% as of today's recent price of $15.60.

Watch for Direxion Daily Small Cap Bear 3X Shares to Potentially Pullback After Gaining 3.32% Yesterday
Comtex SmarTrend(R) - Tue Mar 11, 5:18PM CDT
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $14.59 to a high of $15.43. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $15.07 on volume of 18.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.80% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Mar 03, 4:47PM CST
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $15.65 to a high of $16.31. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $16.00 on volume of 20.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Direxion Daily Small Cap Bear 3X Shares Rises 1.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Mar 03, 4:47PM CST
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $15.65 to a high of $16.31. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $16.00 on volume of 20.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Direxion Daily Small Cap Bear 3X Shares Set to Possibly Rebound After Yesterday's Selloff of 2.63%
Comtex SmarTrend(R) - Mon Feb 24, 5:18PM CST
Direxion Daily Small Cap Bear 3X Shares (NYSE:TZA) traded in a range yesterday that spanned from a low of $15.66 to a high of $16.29. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $16.16 on volume of 14.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading